341 related articles for article (PubMed ID: 18310062)
1. Anti-HLA-DR-triggered monocytes mediate in vitro T cell anergy.
Kriegel MA; Adam-Klages S; Gabler C; Blank N; Schiller M; Scheidig C; Kalden JR; Lorenz HM
Int Immunol; 2008 Apr; 20(4):601-13. PubMed ID: 18310062
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
Moriya N; Sanjoh K; Yokoyama S; Hayashi T
J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
[TBL] [Abstract][Full Text] [Related]
3. Counter-antigen presentation: fibroblasts produce cytokines by signalling through HLA class II molecules without inducing T-cell proliferation.
Ohyama H; Nishimura F; Meguro M; Takashiba S; Murayama Y; Matsushita S
Cytokine; 2002 Feb; 17(4):175-81. PubMed ID: 11991669
[TBL] [Abstract][Full Text] [Related]
4. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody.
Wakamoto S; Fujihara M; Sakagawa H; Takahashi D; Niwa K; Morioka M; Sato S; Kato T; Azuma H; Ikeda H
Transfusion; 2008 Oct; 48(10):2060-8. PubMed ID: 18564388
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking HLA-DR molecules on Th1 cells induces anergy in association with increased level of cyclin-dependent kinase inhibitor p27(Kip1).
Kudo H; Matsuoka T; Mitsuya H; Nishimura Y; Matsushita S
Immunol Lett; 2002 Apr; 81(2):149-55. PubMed ID: 11852120
[TBL] [Abstract][Full Text] [Related]
6. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes.
Corrigall VM; Solau-Gervais E; Panayi GS
Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766
[TBL] [Abstract][Full Text] [Related]
7. R24 anti-GD3 ganglioside antibody can induce costimulation and prevent the induction of alloantigen-specific T cell clonal anergy.
Boussiotis VA; Pardo NA; Collins H; Houghton A; Ritz J; Nadler LM; Soiffer RJ
Eur J Immunol; 1996 Sep; 26(9):2149-54. PubMed ID: 8814260
[TBL] [Abstract][Full Text] [Related]
8. Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
Setterblad N; Garban F; Weigl R; Assier E; Drillat P; Charron D; Dickinson A; Greinix H; Mooney N
Transfusion; 2008 Jan; 48(1):169-77. PubMed ID: 17900279
[TBL] [Abstract][Full Text] [Related]
9. Inhibition by anti-HLA class II monoclonal antibodies of monocyte-dependent T cell proliferation induced by monoclonal antibody OKT3.
Ruggiero G; Manzo C; Fontana S; Scala G; Pirozzi G; Ferrone S; Zappacosta S
Eur J Immunol; 1987 Nov; 17(11):1585-92. PubMed ID: 2824212
[TBL] [Abstract][Full Text] [Related]
10. The cyclin-dependent kinase inhibitors p27Kip1 and p21Cip1 are not essential in T cell anergy.
Verdoodt B; Blazek T; Rauch P; Schuler G; Steinkasserer A; Lutz MB; Funk JO
Eur J Immunol; 2003 Nov; 33(11):3154-63. PubMed ID: 14579284
[TBL] [Abstract][Full Text] [Related]
11. Functional abolition of monocyte HLA-DR by aldehyde treatment. A novel approach to studies of class II restriction elements in antigen presentation.
Rhodes J; Tite J
J Immunol; 1988 May; 140(10):3344-51. PubMed ID: 3361123
[TBL] [Abstract][Full Text] [Related]
12. IL-10-dependent down-regulation of MHC class II expression level on monocytes by peritoneal fluid from endometriosis patients.
Lee KS; Baek DW; Kim KH; Shin BS; Lee DH; Kim JW; Hong YS; Bae YS; Kwak JY
Int Immunopharmacol; 2005 Nov; 5(12):1699-712. PubMed ID: 16102520
[TBL] [Abstract][Full Text] [Related]
13. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
Li L; Iwamoto Y; Berezovskaya A; Boussiotis VA
Nat Immunol; 2006 Nov; 7(11):1157-65. PubMed ID: 17013388
[TBL] [Abstract][Full Text] [Related]
14. Ia antigen on peripheral blood mononuclear leukocytes in man. I. Expression, biosynthesis, and function of HLA-DR antigen non-T cells.
Engleman EG; Charron DJ; Benike CJ; Stewart GJ
J Exp Med; 1980 Aug; 152(2 Pt 2):99s-113s. PubMed ID: 6967944
[TBL] [Abstract][Full Text] [Related]
15. A novel approach to induce human DCs from monocytes by triggering 4-1BBL reverse signaling.
Ju S; Ju S; Ge Y; Qiu H; Lu B; Qiu Y; Fu J; Liu G; Wang Q; Hu Y; Shu Y; Zhang X
Int Immunol; 2009 Oct; 21(10):1135-44. PubMed ID: 19684160
[TBL] [Abstract][Full Text] [Related]
16. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
Mueller RB; Skapenko A; Grunke M; Wendler J; Stuhlmuller B; Kalden JR; Schulze-Koops H
Arthritis Rheum; 2005 Feb; 52(2):451-60. PubMed ID: 15692975
[TBL] [Abstract][Full Text] [Related]
17. Lymphokine activation of T4+ T lymphocytes and monocytes.
Cruikshank WW; Berman JS; Theodore AC; Bernardo J; Center DM
J Immunol; 1987 Jun; 138(11):3817-23. PubMed ID: 3108375
[TBL] [Abstract][Full Text] [Related]
18. The humanized anti-HLA-DR moAb, IMMU-114, depletes APCs and reduces alloreactive T cells: implications for preventing GVHD.
Chen X; Chang CH; Stein R; Goldenberg DM
Bone Marrow Transplant; 2012 Jul; 47(7):967-80. PubMed ID: 22020022
[TBL] [Abstract][Full Text] [Related]
19. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-beta-mediated suppressive activity on T lymphocytes.
Valenti R; Huber V; Filipazzi P; Pilla L; Sovena G; Villa A; Corbelli A; Fais S; Parmiani G; Rivoltini L
Cancer Res; 2006 Sep; 66(18):9290-8. PubMed ID: 16982774
[TBL] [Abstract][Full Text] [Related]
20. In vitro effects of solubilized HLA-DR--role in immunoregulation?
Claus R; Hausmann S; Zavazava N; Walzel H; Schulze HA; Köhler H; Friemel H; Müller-Ruchholtz W
Cell Immunol; 1994 May; 155(2):476-85. PubMed ID: 8181077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
